Theratechnologies to Present at Upcoming Investor Conferences in September

Rhea-AI Summary

Theratechnologies, a biopharmaceutical company (TSX: TH, NASDAQ: THTX), announced its participation in two investor conferences this September. President and CEO Paul Lévesque will present at both events:

1. H.C. Wainwright 26th Annual Global Investment Conference (Sept. 9-11, 2024) at Lotte New York Palace Hotel. A virtual presentation will be available to attendees on Sept. 9.

2. 2024 Cantor Global Healthcare Conference (Sept. 17-19, 2024) at InterContinental Barclay Hotel, New York. Lévesque will participate in a fireside chat on Sept. 18 from 8:00-8:30 a.m. ET.

The management team will be available for one-on-one meetings during both conferences, providing opportunities for investors to engage directly with the company.

News Market Reaction – THTX

+0.41%

1 alert

+0.41% News Effect

On the day this news was published, THTX gained 0.41%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company’s President and CEO, Paul Lévesque will be presenting at two investor conferences in September. Members of the Theratechnologies management team will also be available for one-on-one meetings throughout the conferences.

H.C. Wainwright 26th Annual Global Investment Conference
Date:	September 9-11, 2024
Location:	Lotte New York Palace Hotel
Presentation Details:	Virtual presentation accessible online to conference attendees on the morning of Monday, September 9, 2024
2024 Cantor Global Healthcare Conference
Date:	September 17-19, 2024
Location:	InterContinental Barclay Hotel, New York
Presentation Details:	Fireside chat on Wednesday, September 18 at 8:00-8:30 a.m. ET in Track 4, Empire Ballroom 1

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on LinkedIn and X (formerly Twitter). 

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800

FAQ

When and where is Theratechnologies (THTX) presenting at the H.C. Wainwright Global Investment Conference in September 2024?

Theratechnologies will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024. The conference takes place from September 9-11, 2024, at the Lotte New York Palace Hotel.

What is the date and time of Theratechnologies' (THTX) presentation at the 2024 Cantor Global Healthcare Conference?

Theratechnologies will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, from 8:00-8:30 a.m. ET in Track 4, Empire Ballroom 1.

Who will be representing Theratechnologies (THTX) at the September 2024 investor conferences?

Paul Lévesque, the President and CEO of Theratechnologies, will be presenting at both investor conferences in September 2024. Additionally, members of the Theratechnologies management team will be available for one-on-one meetings.

Will Theratechnologies (THTX) offer one-on-one meetings with investors at the September 2024 conferences?

Yes, members of the Theratechnologies management team will be available for one-on-one meetings throughout both conferences in September 2024.